Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Burns John Thomas, holds the title of CFO at SELLAS Life Sciences Group, Inc..
On 2026-11-18, the insider transacted 3,831 shares.The shares were transacted at a weighted average price of $19.18 per share, resulting in a total market-relevant value of $73K.
Burns John Thomas (CFO) sold $73K of $SLS
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.